SYNOPSIS Investigations into the standardization and reproducibility of the urinary excretion method for determining the absorption of tritiated folic acid were carried out. By proper timing of tissueloading doses of folic acid a clear difference between the percentage excretion ranges of normal and coeliac subjects was obtained. In addition conditions were found whereby the procedure could be repeated on an individual up to four times with reproducible results. Methotrexate in pharmacological amounts was found to have no inhibitory effect on the human intestinal absorption of a small oral dose (300f ,g) of folic acid as determined by this method. This indicates that reduction of folic acid is not necessary for its absorption in man.
The tritiated folic acid (3H-pteroylglutamic acid, 3H-PGA) excretion test was originally described by Anderson, Belcher, Chanarin, and Mollin (1960) and has been used since by several authors (Klipstein, 1963; Kinnear, Johns, tMacIntosh, Burgen, and Cameron, 1963; Halsted, Griggs, and Harris, 1967; and Kremenchuzky, Musso, Hoffbrand, and RochnaViola, 1967) . The absorption of an oral dose of labelled folic acid is assessed by measuring the percentage which is excreted in the urine. The quantity of the test dose used has varied considerably but it is possible to use 300 ,ug which is approximately equivalent to the folate content of a normal meal (Butterworth, Santini, and Frommeyer, 1963; Hurdle, 1967; Chanarin, 1958) . The test can provide a quantitative measure of the absorption of folic acid under nearly normal conditions, and is simple and convenient for both the patient and the investigator.
The test employs a flushing dose of folic acid to displace the labelled compound from the body. Most authors have, at various intervals before the test, attempted to saturate the body tissues with folic acid so as to reduce the amount of the labelled PGA 'Please address requests for reprints to Dr D. G. Weir, Department of Gastroenterology, Sir Patrick Dun's Hospital, Dublin 2.
Received for publication 7 February 1973. taken up by the tissues. This precaution is particularly necessary in vitamin B12-or folate-deficient patients (Chanarin, Anderson, and Mollin, 1958; Klipstein, 1963) .
Previous studies with normal subjects have shown a mean 24-hour excretion of approximately 45 %, but there has been considerable variation in the values, thus limiting the usefulness of the test for comparative studies. In addition, the possibility of carrying out sequential investigations using a patient as his or her own control has never been assessed. In this communication certain modifications of the test procedure are presented which improve its reproducibility and utility.
The intestinal absorption of folic acid in man is of interest for many reasons. While it is probable that in the intact cell all of the vitamin exists in reduced and conjugated forms and no folic acid as such is present, it seems likely that during the preparation of food oxidation gives rise to at least some folic acid (Butterworth et al, 1963) . Due to its stability and commercial availability both in radioactive and non-radioactive form, folic acid has tended to be used as a model compound to study folate absorption (Chanarin, 1969) . Some controversy has arisen as to whether folic acid is reduced and methylated during transfer through the mucosal cells. It has been suggested by some workers that such reduction takes place (Baker, Frank, Feingold, Ziffer, Gellene, Leevy, and Sobotka, 1965; Cohen, 1965) , but more recent studies have shown that while partly reduced folates may be further reduced and methylated (Chanarin and Perry, 1969) folic acid itself is absorbed largely unchanged into the portal blood (Whitehead and Cooper, 1967; Butterworth, Baugh, and Krumdieck, 1969; Leeming, Portman-Graham, and Blair, 1972) . Chanarin and Perry (1969) suggest that it may be absorbed partly unchanged since dihydrofolate reductase has a limited ability to reduce it. At odds with these latter observations is the marked inhibition of folic acid absorption elicited by methotrexate in the rat (Burgen and Goldberg, 1962; Hepner, 1969) . If methotrexate, which is a potent inhibitor of folic acid reduction, does in fact inhibit absorption, it would suggest that reduction of folic acid is in fact involved in its absorption. We have investigated the effect of large oral doses of the drug on folic acid absorption and conclude that it has no significant effect in the human intestine.
Materials and Methods

PREPARATION OF TRITIATED FOLIC ACID (3H-PGA)
Folic acid (Cyanamid of Great Britain, Gosport, Hants) uniformly labelled by tritium gas exposure (Johns, Sperti, and Burgen, 1961) The interval between the tests was varied from 24 to 144 hours. Subjects were either fasted overnight or allowed to have an early light breakfast. Their bladders were emptied just before the test. The 3H-PGA dose was taken orally in 100 ml of water and followed by 200 ml of water. A further 15 mg of folic acid was then given intramuscularly in order to flush all the absorbed 3H-PGA into the urine, the so called 'flushing dose'. Urine was then collected for 24 hours, the volume recorded, and aliquots were stored at -20°C. Intake of fluids was encouraged during this period and a normal diet resumed two hours after dose administration.
ASSAY OF URINE RADIOACTIVITY
Urine samples (1-0 ml) were pipetted in triplicate into glass scintillation counting vials containing 10 ml toluene Triton X-100 scintillant fluid (Turner, 1969) . The scintillation fluid was prepared by adding 700 ml Triton X-100 to 1 400 ml toluene containing 0-14 g POPOP and 5-6 g PPO. Activitywasdetermined in a Tricarb liquid scintillation spectrometer (Packard model 3380) at 5°C and the counting error never exceeded 2-5 %. The vials were recounted after the addition of 60 ,u (approximately 9000 dpm) 1, 2 (3H) n hexadecane (The Radiochemical Centre, Amersham, Bucks, UK) which served as an internal standard. Overall efficiencies of counting intheurine by this method varied from 16 to 30%.
MICROBIOLOGICAL ASSAY OF SERUM, BILE, AND TEST DOSES
Blood was collected in 5 ml disposable plastic syringes and allowed to clot for two to four hours. The serum was removed and centrifuged at 3000 g for 10 min to compact any cells not removed in the clot. It was then transferred to a plastic tube containing 0-05 ml 50% (w/v) potassium ascorbate pH 6-1 and mixed thoroughly. Bile was collected from patients with T-tube drainage following cholecystectomy into plastic tubes as above. In addition 3 ml samples of test dose were stored in plastic tubes as above. All samples were frozen at -20°C until analysis.
All specimens were assayed with a chloramphenicol-resistant strain of L. casei (NCIB. 10463) following a modification of the method described by Millbank, Davis, Rawlins, and Waters (1970) . Dehydrated folic acid (PGA) assay medium BBL was used throughout at half the recommended strength and contained 0-1 ml polyoxyethylene sorbitol monooleate (Sigma), 1 0 g of potassium ascorbate, and 10 to 20 mg chloramphenicol (Chloromycetin, Parke Davis & Co, Hounslow, London, UK) per litre. Ten or 20-,ul samples of serum, bile, etc, were assayed directly in triplicate using a final volume of 5 0 ml medium contained in disposable plastic tubes. The results with this method are similar to those reported for a more conventional method (Spray and Temperley, 1966) as well as possessing the advantages of the aseptic addition technique (Bakerman, 1961) .
SUBJECTS
Twenty-six control subjects were selected from informed volunteer patients showing no gastroenterological, haematological, or renal disorders. Eight patients with coeliac disease were also studied, the diagnosis being confirmed by jejunal biopsy and response to a gluten-free diet. The subjects studied for the effect of methotrexate ranged from having no previous methotrexate to extensive methotrexate treatment over the previous year. All were diagnosed as having the skin disease psoriasis and had been given or were about to be given methotrexate as part of their therapy. None had any known haematological, gastrointestinal, or renal problems. Previous treatment with methotrexate had always been with a single 10 mg dose (orally as four 2 5 mg tablets) administered at regular intervals over the time stated.
ADMINISTRATION OF METHOTREXATE DURING TEST
The drug was administered in some instances 60 minutes before the test dose of oral folic acid or in solution simultaneously with it.
Results
3H-PGA EXCRETION IN NORMAL AND COELIAC SUBJECTS
Twenty-six control subjects had a mean excretion of 45*4 (SD ± 7 3) % with a range of 30 to 57 %. Eight patients with coeliac disease had a mean excretion of 13-4 (SD ± 5-6)% with a range of 7 to 21%.
THE EFFECT OF THE INTERVAL BETWEEN THE LOADING DOSE AND THE TEST PROCEDURE
Reproducibility of the procedure with a three-to sixday interval between the loading dose and the test Ten subjects had a series of three to four tests performed. They had a loading dose 24 hours before the initial test. Subsequently the flushing dose of each test served as the loading dose for the next test. A mean excretion value of 47 9 (SD ± 5 5)% with a range of 38 to 55 % was achieved for the initial test. The test was repeated three to six days later and the mean excretion fell to 29-2 (SD ± 16-5) %, range 9 to 67%. When repeated on the third or fourth occasion at seven to 14 days or 15 to 21 days the values were 20 5 (SD ± 13-3) %, range 5 to 40 %, and 20-0 (SD ± 7 25) %, range 11 to 28%, respectively. The intraindividual variation between each test was large and the means were significantly different at p < 0 0025 level. These results are shown in figure 1. Certain points should be emphasized concerning the changes in the technique advocated. The precision of the test procedure can be enhanced in the following ways. The tritiated folic acid must be of high purity and stock solutions should be monitored routinely by spectrophotometry and bioassay to detect degradation during storage. The use of toluene Triton X-100 scintillant for determining the tritium activity in the urine has given a higher efficiency and reproducibility than the scintillants used in previous studies (Anderson et al, 1960; Kinnear et al, 1963; Halsted et al, 1967) . Adherence to these points has enabled the oral dose of tritiated folic acid to be reduced from the 10 to 20 ,uCi level used by other authors to a 3 to 4 pCi dose, thus enhancing the safety of the procedure and reducing its cost.
Perhaps the most surprising feature of this study has been the importance of the timing of the tissue loading doses of folic acid when assessing the reproducibility of the test in the same individual. If the loading dose is given four or more days before the test the percentage of the dose excreted falls when compared with the level obtained when the loading dose is given 24 hours before the test (figs 1 and 2), which would suggest that the degree of tissue saturation decreases rapidly. This is supported by the findings of Kinnear et al (1963) who demonstrated in 11 control subjects that comparable results could be obtained when the tritiated folic acid absorption test was repeated at a week's interval if a daily parental dose of 30 mg of PGA was given during the week.
Other studies of this procedure have concentrated mainly on the size and timing of the parenteral flushing dose of PGA. Anderson et al (1960) strated that varying the size of the flushing dose from 5 to 15 mg or changing the timing of the injection from two hours before to two hours after the labelled oral dose had no effect on the percentage of the latter subsequently excreted in the urine. The effect of varying the timing of the loading dose on the reproducibility of this test has not previously been reported.
Using this technique it is possible to perform duplicate studies on the same individual over a 48-hour period by using the flushing dose of the first test as the loading dose of the second test (fig 1) . A possible drawback of this procedure could be the excretion of the radioactivity given in the first test continuing into the second 24-hour collection period. It has been found, however, that the 3H-PGA excretion carried over into the second and third days was less than 4 % and 1 % respectively when further parenteral folic acid flushing doses were given on each day. This degree of overlap is considered to be within the experimental error of the technique and its effect can be minimized either by randomizing the duplicate studies or by repeating the test on the third or fourth day as long as parenteral folate injections are given on each intervening day in order that complete tissue saturation be maintained. Since 90% of the tritium label excreted appeared within the first eight hours, it should be possible in routine clinical practice to measure the absorption of folic acid by collecting the urine over relatively short periods and accordingly could be done in association with the d-xylose absorption test. Rosenberg and Godwin (1971) have suggested that the flushing dose should be given at least four hours after the oral labelled folate to avoid a possible dilution of the oral test dose by biliary folate excretion. In fact the total biliary folate excretion during the first hour following the parenteral folate was found to be less than 1 % of the oral dose, as measured via T tube drainage in cholecystectomy patients, and is accordingly unlikely to affect significantly the intestinal milieux in regard to the absorption of the oral dose.
The multiple parenteral administrations of folic acid which are intended to maintain tissue store saturation does cause a rise in serum folate level measured at the time of the test dose (ie, 24 hours after the last parenteral dose) but not to a value outside the normal range (Herbert, Baker, Frank, Pasher, Sobotka, and Wassermann, 1960 ). This finding is probably of little significance as regards folate absorption as there appears to be no relationship between the percentage absorption and the serum folate level (Hepner, Booth, Cowan, Hoffbrand, and Mollin, 1968) .
Thus the measurement of the urinary excretion of 3H-PGA following an oral dose is a simple procedure which can give reproducible results in the same individual and can also differentiate between normal and coeliac subjects. It has previously been demonstrated by faecal excretion studies that approximately 80% of a single small dose of tritiated folic acid is absorbed from the human intestine (Anderson et al, 1960; Jeejeebhoy, Ramanath, Mehan, Pathare, Parekh, Nadkami, and Ganatra, 1967) . Of this absorbed folic acid it would appear that by the simultaneous administration of a large flushing dose of unlabelled folic acid, and in addition previously saturating the tissue stores with the vitamin, only some 50% of the oral dose can be found in the first 24-hour urine collection (Anderson et al, 1960) . It would appear that even with saturation and flushing some 20% of the tritium label gets taken up by the tissues and retained for a period greater than 24 hours. This is further supported by the intravenous studies of Johns and his coworkers (Johnset al, 1961) who found that even at very high concentrations some of the intravenously administered folic acid was retained longer than 24 hours.
We have found that the administration of methotrexate significantly raises the amount of radioactive folic acid excreted from a small oral dose over what is found in normal circumstances. In the normal group a mean of 45 4 (SD ± 7.3)% of a 300 jug dose of tritium-labelled folic acid was excreted in the first 24-hour urine collection; however, when methotrexate was administered with the labelled folic acid the mean value was elevated to 54 9 (SD ± 6 5) % (table I). In no instance did any 24-hour urinary excretion fall significantly below the mean excretion value of 45 4 % found for normals. Chanarin and Bennett (1962) observed an increased urinary Streptococcus faecalis activity after daily parenteral folic acid in one subject who had previously been on methotrexate therapy. These authors considered that the increased excretion of folic acid was related to defective tissue cell uptake. Another possibility would be that methotrexate blocks tissue cell utilization of folic acid rather than transport into the cell per se. Preliminary observations in this laboratory (Brown, Houlihan, Davidson, and Scott, 1973) The outbreak described by Gross, Rowe, and Easton (1973) is of interest because we have recently encountered a similar outbreak with four cases in our own premature baby unit (Gwynn and George, 1973) and know of one further case in another baby unit in this city (Bridgwater, 1972, personal communication) . Citrobacter koseri may therefore be a more frequent cause of neonatal meningitis than has been recognized in the past and its potential pathogenicity in baby units seems clear. Studies in our own unit suggested that intestinal carriage was important. The organism was recovered from the bowel of several unaffected infants and also from a member of staff at one stage. The outbreak was controlled, without need for closing the unit, by regular screening of all babies and by isolating carriers. The unit has remained free of the organism in the 10 months since the outbreak. Sensitive methods for detecting the organism were required and we find overnight culture of a saline suspension of stool in selenite F with subculture to MacConkey agar containing 10 ug/nml ampicillin most useful in this respect.
A more detailed account of our methods and of the incidence of this organism in different situations is being prepared for publication.
